Journal of Clinical Pediatrics ›› 2023, Vol. 41 ›› Issue (12): 903-907.doi: 10.12372/jcp.2023.22e1553
• Urinary System Disease • Previous Articles Next Articles
WANG Meiqiu1, HE Xu2, WANG Ren2, JIA Lili2, GAO Chunlin2, XIA Zhengkun1()
Received:
2022-11-22
Published:
2023-12-15
Online:
2023-12-04
WANG Meiqiu, HE Xu, WANG Ren, JIA Lili, GAO Chunlin, XIA Zhengkun. Risk factors of poor renal prognosis in children with Henoch-Schönlein purpura nephritis[J].Journal of Clinical Pediatrics, 2023, 41(12): 903-907.
"
项 目 | 预后良好组(n=445) | 预后不良组(n=31) | 统计量 | P |
---|---|---|---|---|
男性[n(%)] | 258(58.0) | 20(60.5) | χ2=0.51 | 0.475 |
发病年龄[M(P25~P75)]/岁 | 10.5(8.0~13.2) | 12.6(11.5~13.3) | Z=2.29 | 0.022 |
皮疹到肾脏受累时间[M(P25~P75)]/d | 11.0(0.0~31.0) | 0.0(0.0~31.0) | Z=1.02 | 0.307 |
肾脏受累到肾穿时间[M(P25~P75)]/d | 36.0(19.0~101.5) | 86.0(37.0~531.0) | Z=3.22 | 0.001 |
肉眼血尿[n(%)] | 67(15.1) | 4(12.9) | - | 1.0001) |
腹痛[n(%)] | 185(41.6) | 12(38.7) | χ2=0.10 | 0.754 |
关节痛[n(%)] | 153(34.4) | 7(22.6) | χ2=1.81 | 0.179 |
随访时间[M(P25~P75)]/月 | 33.8(20.9~53.8) | 34.5(21.2~89.8) | Z=1.07 | 0.284 |
贫血[n(%)] | 77(17.3) | 7(22.6) | χ2=0.56 | 0.456 |
低血清白蛋白[n(%)] | 19(4.3) | 2(6.5) | - | 0.6391) |
高胆固醇[n(%)] | 132(29.7) | 15(48.4) | χ2=4.76 | 0.029 |
高尿酸血症[n(%)] | 51(11.5) | 10(32.3) | - | 0.0031) |
eGFR<90 mL/(min·1.73 m2)[n(%)] | 9(2.0) | 4(12.9) | - | 0.0071) |
大量蛋白尿[n(%)] | 50(11.2) | 9(29.0) | - | 0.0081) |
高尿NAG酶[n(%)] | 293(65.8) | 24(77.4) | χ2=1.75 | 0.186 |
高尿RBP[n(%)] | 68(15.3) | 13(41.9) | χ2=14.58 | <0.001 |
高尿C3[n(%)] | 158(35.5) | 11(35.5) | χ2=0.00 | 0.998 |
高尿α2-M[n(%)] | 57(12.8) | 7(22.6) | - | 0.1661) |
RAS阻滞剂[n(%)] | 177(39.8) | 12(38.7) | χ2=0.01 | 0.907 |
应用泼尼松[n(%)] | 401(90.1) | 29(93.6) | - | 0.7561) |
甲泼尼龙冲击治疗[n(%)] | 158(35.5) | 12(38.7) | χ2=0.13 | 0.719 |
应用免疫抑制剂[n(%)] | 175(39.3) | 8(25.8) | χ2=2.24 | 0.135 |
[1] | Carucci NS, La Barbera G, Peruzzi L, et al. Time of onset and risk factors of renal involvement in children with Henoch-Schönlein purpura: retrospective study[J]. Children (Basel), 2022, 9(9): 1394. |
[2] |
Trapani S, Micheli A, Grisolia F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature[J]. Semin Arthritis Rheum, 2005, 35(3): 143-153.
doi: 10.1016/j.semarthrit.2005.08.007 |
[3] |
Xu S, Han S, Dai Y, et al. A review of the mechanism of vascular endothelial injury in immunoglobulin A vasculitis[J]. Front Physiol, 2022, 13: 833954.
doi: 10.3389/fphys.2022.833954 |
[4] | Shang XP, Wu JG, Cheng Y, et al. Epidemiology and clinical characteristics of Henoch-Schönlein purpura associated with Mycoplasma pneumoniae infection in 131 children in Hubei Province, China[J]. Mediterr J Hematol Infect Dis, 2021, 13(1): e2021037. |
[5] |
Zhong ZX, Tan JX, Tang Y, et al. Crescent lesions are not a predictive factor in adult-onset Henoch-Schönlein purpura nephritis[J]. Clin Exp Med, 2019, 19(4): 449-456.
doi: 10.1007/s10238-019-00567-6 |
[6] |
Kang Z, Xun M, Li Z, et al. Association of the clini-copathological characteristics and proteinuria remission of pediatric IgAV with nephrotic-range proteinuria: a retrospective cohort study[J]. Front Pediatr, 2022, 10: 959212.
doi: 10.3389/fped.2022.959212 |
[7] | 中华医学会儿科学分会肾脏学组. 紫癜性肾炎诊治循证指南(2016)[J]. 中华儿科杂志, 2017, 55(9): 647-651. |
[8] |
Noone DG, Marks SD. Hyperuricemia is associated with hypertension, obesity, and albuminuria in children with chronic kidney disease[J]. J Pediatr, 2013, 162(1): 128-132.
doi: 10.1016/j.jpeds.2012.06.008 |
[9] | Jančič SG, Močnik M, Marčun Varda N. Glomerular filtration rate assessment in children[J]. Children (Basel), 2022, 9(12): 1995. |
[10] |
Giavarina D, Husain-Syed F, Ronco C. Clinical implications of the new equation to estimate glomerular filtration rate[J]. Nephron, 2021, 145(5): 508-512.
doi: 10.1159/000516638 |
[11] |
Xu K, Zhang L, Ding J, et al. Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis[J]. J Nephrol, 2018, 31(2): 279-286.
doi: 10.1007/s40620-017-0457-z pmid: 29185209 |
[12] |
Haas M, Verhave JC, Liu ZH, et al. A multicenter study of the predictive value of crescents in IgA nephropathy[J]. J Am Soc Nephrol, 2017, 28(2): 691-701.
doi: 10.1681/ASN.2016040433 pmid: 27612994 |
[13] |
Pohl M. Henoch-Schönlein purpura nephritis[J]. Pediatr Nephrol, 2015, 30(2): 245-252.
doi: 10.1007/s00467-014-2815-6 pmid: 24733586 |
[14] |
Song Y, Huang X, Yu G, et al. Pathogenesis of IgA vasculitis: an up-to-date review[J]. Front Immunol, 2021, 12: 771619.
doi: 10.3389/fimmu.2021.771619 |
[15] |
Yun D, Kim DK, Oh KH, et al. MEST-C pathological score and long-term outcomes of child and adult patients with Henoch-Schönlein purpura nephritis[J]. BMC Nephrol, 2020, 21(1): 33.
doi: 10.1186/s12882-020-1691-5 pmid: 32000703 |
[16] |
Jimenez A, Chen A, Lin JJ, et al. Does MEST-C score predict outcomes in pediatric Henoch-Schönlein purpura nephritis?[J]. Pediatr Nephrol, 2019, 34(12): 2583-2589.
doi: 10.1007/s00467-019-04327-2 pmid: 31402405 |
[17] |
Çakıcı EK, Gür G, Yazılıtaş F, et al. A retrospective analysis of children with Henoch-Schonlein purpura and re-evaluation of renal pathologies using Oxford classification[J]. Clin Exp Nephrol, 2019, 23(7): 939-947.
doi: 10.1007/s10157-019-01726-5 pmid: 30895528 |
[18] |
Kim CH, Lim BJ, Bae YS, et al. Using the Oxford classification of IgA nephropathy to predict long-term outcomes of Henoch-Schönlein purpura nephritis in adults[J]. Mod Pathol, 2014, 27(7): 972-982.
doi: 10.1038/modpathol.2013.222 |
[19] |
Inagaki K, Kaihan AB, Hachiya A, et al. Clinical impact of endocapillary proliferation according to the Oxford classification among adults with Henoch-Schönlein purpura nephritis: a multicenter retrospective cohort study[J]. BMC Nephrol, 2018, 19(1): 208.
doi: 10.1186/s12882-018-1009-z pmid: 30119643 |
[20] |
Li X, Tang M, Yao X, et al. A clinicopathological comparison between IgA nephropathy and Henoch-Schönlein purpura nephritis in children: use of the Oxford classification[J]. Clin Exp Nephrol, 2019, 23(12): 1382-1390.
doi: 10.1007/s10157-019-01777-8 pmid: 31468231 |
[21] |
Huang X, Ma L, Ren P, et al. Updated Oxford classification and the international study of kidney disease in children classification: application in predicting outcome of Henoch-Schönlein purpura nephritis[J]. Diagn Pathol, 2019, 14(1): 40.
doi: 10.1186/s13000-019-0818-0 pmid: 31077245 |
[22] |
Delbet JD, Geslain G, Auger M, et al. Histological prognostic factors in children with Henoch-Schönlein purpura nephritis[J]. Pediatr Nephrol, 2020, 35(2): 313-320.
doi: 10.1007/s00467-019-04363-y |
[23] |
Hastings MC, Rizk DV, Kiryluk K, et al. IgA vasculitis with nephritis: update of pathogenesis with clinical implications[J]. Pediatr Nephrol, 2022, 37(4): 719-733.
doi: 10.1007/s00467-021-04950-y |
[24] | Hahn D, Hodson EM, Craig JC. Interventions for preventing and treating kidney disease in IgA vasculitis[J]. Cochrane Database Syst Rev, 2023, 2(2): Cd005128. |
[25] |
Lai L, Liu S, Azrad M, et al. IgA vasculitis with nephritis in adults: histological and clinical assessment[J]. J Clin Med, 2021, 10(21): 4851.
doi: 10.3390/jcm10214851 |
[26] |
Edström Halling S, Söderberg MP, Berg UB. Predictors of outcome in Henoch-Schönlein nephritis[J]. Pediatr Nephrol, 2010, 25(6): 1101-1108.
doi: 10.1007/s00467-010-1444-y pmid: 20174831 |
[27] |
Sobotka R, Čapoun O, Kalousová M, et al. Prognostic importance of vitamins A, E and retinol-binding protein 4 in renal cell carcinoma patients[J]. Anticancer Res, 2017, 37(7): 3801-3806.
pmid: 28668878 |
[28] |
Shi D, Chan H, Yang X, et al. Risk factors associated with IgA vasculitis with nephritis (Henoch-Schönlein purpura nephritis) progressing to unfavorable outcomes: a meta-analysis[J]. PLoS One, 2019, 14(10): e0223218.
doi: 10.1371/journal.pone.0223218 |
[1] | LUO Mingjing, YU Jiaming, WANG Xiaodong, ZHANG Xiaoling, YU Yue, ZHANG Yu, WEN Feiqiu, LIU Sixi. Clinical analysis of invasive fungal disease secondary to allogeneic hematopoietic stem cell transplantation in 424 children with thalassemia [J]. Journal of Clinical Pediatrics, 2025, 43(1): 21-28. |
[2] | LIU Dongxia, JIN Rong, LIN Rongjun. Risk factors analysis of severe refractory Mycoplasma pneumoniae pneumonia complicated with bronchitis obliterans in children [J]. Journal of Clinical Pediatrics, 2025, 43(1): 29-34. |
[3] | ZHONG Jinhong, WANG Can, CHEN Fang. Progress in the research of infantile fiberoptic bronchoscopy sedation [J]. Journal of Clinical Pediatrics, 2025, 43(1): 50-55. |
[4] | JIANG Weiqin, WANG Jing, CHENG Anna, CHEN Tingting, HUANG Yujuan. Predictors of recurrent febrile seizures during the same febrile illness in children with febrile seizures [J]. Journal of Clinical Pediatrics, 2025, 43(1): 8-13. |
[5] | QIU Xiu, WEI Dongmei, LIN Shanshan, XIA Huimin, ZHOU Wenhao. Principles and practice of the Born in Guangzhou Cohort Study [J]. Journal of Clinical Pediatrics, 2024, 42(9): 747-752. |
[6] | FAN Jianxia. The origins and development of the healthy life trajectory program: a cohort of community-family-mother-child multidimensional interventions for overweight and obesity in children [J]. Journal of Clinical Pediatrics, 2024, 42(9): 768-773. |
[7] | JIANG Tao, LI Shuangjie, TANG Lian, OUYANG Wenxian. Immunobiological properties of peripheral blood MAIT cells in children with chronic hepatitis B [J]. Journal of Clinical Pediatrics, 2024, 42(9): 787-790. |
[8] | ZHOU Jie, LIU Keqiang, WANG Jinling, WANG Ying. Megacystis-microcolon-intestinal hypoperistalsis syndrome caused by MYH11 elongating mutation : a case report and literatures review [J]. Journal of Clinical Pediatrics, 2024, 42(9): 798-804. |
[9] | CHU Sijia, TANG Jihong. Research progress of central nervous system injury associated with pediatric acute lymphoblastic leukemia and its treatment [J]. Journal of Clinical Pediatrics, 2024, 42(9): 811-816. |
[10] | DING Yaping, XIA Shanshan, ZHANG Chenmei. Interpretation of “2023 Children’s Renal Nutrition Working Group Clinical Practice Recommendations: Nutritional Management of Children with Acute Kidney Injury” [J]. Journal of Clinical Pediatrics, 2024, 42(8): 667-672. |
[11] | LI Yirong, LI Huiping, GAO Jingyu, XIAO Yuhua, CHEN Xiaomin, LU Yanling, ZHAO Nana, FENG Xiaoqin. Comparison of different doses of cytarabine for induction chemotherapy in children with acute myeloid leukemia in FLAG-IDA regimen [J]. Journal of Clinical Pediatrics, 2024, 42(8): 673-677. |
[12] | HUANG Bo, DONG Yanying, SONG Linlan. Clinical characteristics of 348 children with infectious mononucleosis [J]. Journal of Clinical Pediatrics, 2024, 42(8): 678-683. |
[13] | WANG Dan, SHAO Jingbo, LI Hong, ZHANG Na, ZHU Jiashi, FU Pan, WANG Zhen. Clinical analysis of 38 cases of hematological malignancies complicated with tumor lysis syndrome in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 684-690. |
[14] | MA Yan, WEI Xingjiao, BAI Hua, ZHANG Yan, TIAN Xinmin, Aqsa Ahmad, LIANG Lijun. Analysis of etiological composition and clinical features of stage 5 chronic kidney disease in children in a tertiary hospital in western China [J]. Journal of Clinical Pediatrics, 2024, 42(8): 697-703. |
[15] | WANG Ye, ZHANG Linlin, CHI Zuofei, SUN Ruowen, JIANG Zehui, XU Gang. A case of clinical report of T-lymphoblastic lymphoma secondary to acute promyelocytic leukemia in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 722-727. |
|